These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9416907)

  • 1. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice.
    Edwards MH; Pierangeli S; Liu X; Barker JH; Anderson G; Harris EN
    Circulation; 1997 Dec; 96(12):4380-4. PubMed ID: 9416907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies in an in vivo thrombosis model in mice.
    Pierangeli SS; Harris EN
    Lupus; 1994 Aug; 3(4):247-51. PubMed ID: 7804310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies.
    Pierangeli SS; Liu SW; Anderson G; Barker JH; Harris EN
    Circulation; 1996 Oct; 94(7):1746-51. PubMed ID: 8840870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo models of thrombosis for the antiphospholipid syndrome.
    Pierangeli SS; Harris EN
    Lupus; 1996 Oct; 5(5):451-5. PubMed ID: 8902780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model.
    Ferrara DE; Liu X; Espinola RG; Meroni PL; Abukhalaf I; Harris EN; Pierangeli SS
    Arthritis Rheum; 2003 Nov; 48(11):3272-9. PubMed ID: 14613293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.
    Carrera-Marín A; Romay-Penabad Z; Papalardo E; Reyes-Maldonado E; García-Latorre E; Vargas G; Shilagard T; Pierangeli S
    Lupus; 2012 Dec; 21(14):1497-505. PubMed ID: 22933620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies.
    Montiel-Manzano G; Romay-Penabad Z; Papalardo de Martínez E; Meillon-García LA; García-Latorre E; Reyes-Maldonado E; Pierangeli SS
    Ann N Y Acad Sci; 2007 Jun; 1108():540-53. PubMed ID: 17894019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice.
    Pierangeli SS; Barker JH; Stikovac D; Ackerman D; Anderson G; Barquinero J; Acland R; Harris EN
    Thromb Haemost; 1994 May; 71(5):670-4. PubMed ID: 8091396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies.
    Espinola RG; Pierangeli SS; Gharavi AE; Harris EN
    Thromb Haemost; 2002 Mar; 87(3):518-22. PubMed ID: 11916085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome.
    Pierangeli SS; Liu XW; Barker JH; Anderson G; Harris EN
    Thromb Haemost; 1995 Nov; 74(5):1361-7. PubMed ID: 8607123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies.
    Romay-Penabad Z; Liu XX; Montiel-Manzano G; Papalardo De Martínez E; Pierangeli SS
    Ann N Y Acad Sci; 2007 Jun; 1108():554-66. PubMed ID: 17894020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
    Ostertag MV; Liu X; Henderson V; Pierangeli SS
    Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models.
    Pierangeli SS; Liu X; Espinola R; Olee T; Zhu M; Harris NE; Chen PP
    Thromb Haemost; 2000 Sep; 84(3):388-95. PubMed ID: 11019960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.
    Pierangeli SS; Blank M; Liu X; Espinola R; Fridkin M; Ostertag MV; Roye-Green K; Harris EN; Shoenfeld Y
    J Autoimmun; 2004 May; 22(3):217-25. PubMed ID: 15041042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction.
    Miranda S; Billoir P; Damian L; Thiebaut PA; Schapman D; Le Besnerais M; Jouen F; Galas L; Levesque H; Le Cam-Duchez V; Joannides R; Richard V; Benhamou Y
    PLoS One; 2019; 14(3):e0212614. PubMed ID: 30870459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
    Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
    Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.
    Meng H; Yalavarthi S; Kanthi Y; Mazza LF; Elfline MA; Luke CE; Pinsky DJ; Henke PK; Knight JS
    Arthritis Rheumatol; 2017 Mar; 69(3):655-667. PubMed ID: 27696751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies.
    Romay-Penabad Z; Carrera Marin AL; Willis R; Weston-Davies W; Machin S; Cohen H; Brasier A; Gonzalez EB
    Lupus; 2014 Oct; 23(12):1324-6. PubMed ID: 25228739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies.
    Pierangeli SS; Vega-Ostertag ME; Raschi E; Liu X; Romay-Penabad Z; De Micheli V; Galli M; Moia M; Tincani A; Borghi MO; Nguyen-Oghalai T; Meroni PL
    Ann Rheum Dis; 2007 Oct; 66(10):1327-33. PubMed ID: 17261530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombogenic properties of antiphospholipid antibodies do not depend on their binding to beta2 glycoprotein 1 (beta2GP1) alone.
    Gharavi AE; Pierangeli SS; Gharavi EE; Hua T; Liu XW; Barker JH; Anderson GH; Harris EN
    Lupus; 1998; 7(5):341-6. PubMed ID: 9696138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.